FHB focuses on the immune system related services and innovative R&D. Our goal is to establish the cell-based immunotherapies for cancers and autoimmune disorders.

The mission of FHB is to persistently expand the international partnership, promote the clinical trials and obtain the medical certificate.

FHB was founded in December, 2012. The laboratory of FHB is certified with ISO/IEC 17025 of Taiwan Accreditation Foundation (TAF) in February, 2016.

FHB has well-established organization, including board of directors, auditing office, advisory committee, chairman, general manager and general office. The general manager is in charging of eight departments.

FHB sets up a brand new 661 square meters laboratory, which is qualified with Good Tissue Practice and ISO/IEC 17025 of Taiwan Accreditation Foundation (TAF) certificated.

FHB updates the information of health-related seminars, exhibitions and industrial news from time to time. Welcome to subscribe and explore the latest news of us.